COVID-19: What is the correct way to report vaccine-related adverse events?

COVID-19: What is the correct way to report vaccine-related adverse events?

Phase two of South Africa’s COVID-19 vaccine rollout is underway and members of the public are being asked to report any mild, moderate or severe adverse events experienced after receiving their jabs. Adele Baleta explains what the correct way is to report adverse events after vaccination.

Read More

COVID-19 still impacting medical and traditional circumcision in the Eastern Cape

COVID-19 still impacting medical and traditional circumcision in the Eastern Cape

The COVID-19 pandemic and related restrictions have disrupted both traditional male circumcisions and voluntary male circumcisions in the Eastern Cape. Luvuyo Mehlwana reports.

Read More

Employing more nurses can reduce total health costs, study suggests

Employing more nurses can reduce total health costs, study suggests

A recent study published in The Lancet medical journal suggests that employing more nurses can result in cost savings double the cost of employing the additional nurses. The study was conducted in Australia but may well have important implications for nursing in South Africa. Tiyese Jeranji reports.

Read More

COVID-19: One week of vaccines: What are we doing well? What can be done better?

COVID-19: One week of vaccines: What are we doing well? What can be done better?

It has been a week since South Africa started its mass rollout for 60-year-olds and older. Nathan Geffen and Marcus Low assess the rollout so far.

Read More

In-depth: What will it take to actually make mRNA vaccines in SA

In-depth: What will it take to actually make mRNA vaccines in SA

Messenger RNA (mRNA) vaccines, such as the COVID-19 vaccines made by Moderna and Pfizer/BioNTech, have been hailed for their manufacturing advantages over conventional vaccines – so much so that African leaders such as President Cyril Ramaphosa has called for mRNA production capacity to be developed in Africa. Catherine Tomlinson examines why mRNA vaccines are easier to make than some other types of vaccines and asks what it will take to build such production capacity.

Read More

“The system is going to implode”: Cancer treatment backlogs grow after Charlotte Maxeke fire

“The system is going to implode”: Cancer treatment backlogs grow after Charlotte Maxeke fire

Four years ago, the virtual collapse of cancer services in KwaZulu-Natal saw some desperate patients move to Gauteng for care. Now, a new crisis is again prompting those who can, to relocate for treatment. Laura Lopez Gonzalez reports.

Read More

Western Cape to launch COVID-style tuberculosis dashboard

Western Cape to launch COVID-style tuberculosis dashboard

The COVID-19 pandemic caused huge setbacks for the fight against TB. Now, provinces are developing TB catch-up plans. The Western Cape Department of Health will soon launch a TB dashboard as part of its “multi-sectorial TB emergency response plan”. Tiyese Jeranji reports.

Read More

Analysis: We need to do for TB vaccines what we’ve done for COVID-19

Analysis: We need to do for TB vaccines what we’ve done for COVID-19

It is little wonder that some TB vaccine researchers suffer from a rare syndrome that understandably threatens their mental health. Symptoms include frustration, impatience, irritability, seemingly inexplicable rage, and in the least resilient, despair. It’s called VJS or vaccine jealousy syndrome, writes Chris Bateman.

Read More

COVID-19: What provinces have planned for older persons

COVID-19: What provinces have planned for older persons

Phase II of South Africa’s vaccination rollout has started. Elri Voigt unpacks how provinces will go about vaccinating those aged 60 and older.

Read More

Behind the scenes: How the first 500 000 vaccine doses administered in SA were secured

Behind the scenes: How the first 500 000 vaccine doses administered in SA were secured

When South Africa’s rollout of the AstraZeneca vaccine was put on hold in early February, a scramble ensued to ensure healthcare workers could be protected. Chris Bateman spoke to Professor Glenda Gray about the behind-the-scenes negotiations that helped secure 500 000 doses of the Johnson & Johnson vaccine – almost all of which have now been used in the Sisonke study.

Read More

How to vaccinate millions as quickly as possible

How to vaccinate millions as quickly as possible

Starting now, hundreds of thousands of COVID-19 vaccines will be arriving in South Africa weekly. Rather than spending energy and resources policing who gets them, we should be focusing on getting the vaccines as fast as possible into willing arms. Don’t try to micro-manage the rollout, writes Nathan Geffen and Marcus Low.

Read More

1 3 4 5 6 7 67